@article{32701,
  keywords = {leprosy, Dapsone, Sulfone Syndrome},
  author = {Gonçalves TS and Pereira ECG and Netto PRS and Freire RAC and Mendes SUR},
  title = {[Case report: Sulfone Syndrome in leprosy patient]},
  abstract = {<p>We report the case of a woman with leprosy who was treated with MDT-MB/ WHO and presented 4 weeks after the start of treatment, fever, malaise, weakness, jaundice, edema and rashes in feet and hands, hepatitis, pruritus, dysphagia, haemolytic anemia, submandibular lymph node, as well as nausea, vomiting and epigastric pain. Laboratory tests showed decreased hemoglobin, leukocytosis, eosinophilia, increased hepatic transaminases, indirect hyperbilirubinemia, hypoalbuminemia, DHL and elevated TAP. A diagnosis of Dapsone Syndrome was established, treatment of leprosy was suspended and the patient was advised to return treatment after hospital discharge, with replacement of dapsone.</p>
},
  year = {2018},
  journal = {Revista de Patologia do Tocantins},
  volume = {5},
  pages = {28-31},
  url = {http://scholar.google.nl/scholar_url?url=https://sistemas.uft.edu.br/periodicos/index.php/patologia/article/download/5071/14513&hl=nl&sa=X&d=13403405165673474039&scisig=AAGBfm2P00zIuSxYRbZTyyMswQqxytX2aA&nossl=1&oi=scholaralrt&hist=732gnZIAAAAJ:1269093288},
  language = {por, eng},
}